Board Member Profile

ホーム>HOME>Corporate Profile>Board Member Profile

Board Members

Takuya YOKOKAWA
President ＆CEO, Executive Officer
Date of birth: Oct. 13, 1960

Career
Apr. 1985 Joined Fuji Photo Film Co., Ltd. (currently FUJIFILM Corp.(FUJIFILM))
Oct. 1996 Manager, Ashigara Research Laboratories, FUJIFILM
Apr. 2004 Senior manager, Research and Development Management HQ, Digital & Photo Imaging Material Research Laboratories, FUJIFILM
Jun. 2007 Deputy General Manager, life science Research Laboratories, Research and Development Management HQ / Senior Manager, Business Development Office Life Science Business Division, FUJIFILM
Jul. 2008 Toyama Chemical Co., Ltd. (currently FUJIFILM Toyama Chemical Co., Ltd.)　on loan
Jun. 2009 General Manager, Drug Discovery Research Laboratories, Research and Development Management HQ, FUJIFILM
Sep. 2013 General Manager, Regenerative Medicine Business Development Office/Deputy General Manager, Pharmaceutical Products. Div., FUJIFILM
Apr. 2015 Manager, Regenerative Medicine Business Development Office, FUJIFILM /　Forum for Innovative Regenerative Medicine,　on loan
Dec. 2017 Manager, Healthcare Business Development Office, FUJIFILM
Mar. 2018 Director, Perseus Proteomics Inc. (the Company)
Jun. 2018 President & CEO, the Company (to present)
Jan. 2019 Executive Officer, the Company (to present)

Shinji HAGIWARA
Director, Executive Officer, Head of R&D Dept.,
Date of birth: Mar. 23, 1965

Career
Apr. 1989 Sandoz Yakuhin K.K.
May 2001 Team Leader, Biosciences Department, GlaxoSmithKline K.K.
Feb. 2007 Research Manager, life science Research Laboratories, Research & Development Management HQ, FUJIFILM Corporation
Oct. 2013 Senior Manager, Pharmaceutical & Healthcare Research Laboratories, Research & Development Management HQ, FUJIFILM Corporation
Nov. 2021 Head of Business Development Dept. & Deputy Head of Research and Development Dept., the Company
Jun. 2022 Executive Officer, Head of Research and Developmenet Dept., the Company
Jun. 2023 Director, Executive Officer, Head of Research and Developmenet Dept., the Company (to present)

Susumu TANAHASHI
Director, Executive Officer, Head of Administrative Dept. & Business Development Dept.
Date of birth: Feb. 13, 1963

Career
Apr. 1986 Joined Fuji Photo Film Co., Ltd. (currently FUJIFILM Corp.(FUJIFILM))
Oct. 2001 Operations Manager, Photo Imaging Products Sales Department, the Company
Feb. 2009 Manager, Photo Marketing Group, Consumer Marketing Division, the Company
Oct. 2010 Senior Operations Manager, Marketing Group, Photo Imaging Products Division, the Company
Jan. 2011 Senior Operations Manager, Business Strategy Group, Corporate Planning Division, FUJIFILM Holdings Corporation
Jun. 2017 President & Representative Director, FUJIFILM Pharma Co., Ltd.
Jun. 2019 Vice President and Chief Operating Officer, FUJIFILM Toyama Chemical Co., Ltd.
Mar. 2022 President & Representative Director, PDRadiopharma, Inc.
Aug. 2024 Executive Project Manager, FUJIFILM Toyama Chemical Co., Ltd. 
Dec. 2025 Head of Business Development Dept., the company
Apr. 2026 Executive Officer, Head of Business Development Dept., & Deputy Head of Administrative Dept., the Company
Jun. 2026 Director, Executive Officer, Head of Administrative Dept., & Head of Business Development Dept., the Company (to present)

Kinichiro KOMINAMI
Outside Director
Date of birth: Jan. 20, 1967

Career
Jul. 1994 PhD, Researcher, Imperial Cancer Research Fund Laboratories
Sep. 1998 Assistant Professor, Medical Institute of Bioregulation, Kyushu University
Jun. 2001 Joined Nomura Securities, Co., Ltd. (Nomura Securities)
Nomura Research and Advisory Co., Ltd. (NRA) on loan
Jun. 2011 Executive Director, Investment Dept. NRA
Apr. 2013 Section Chief, Regional Financial Institutional and Public Sector Clients Consulting Dept., Nomura Securities
Aug. 2015 Director, Corporate Business Group, Mizuho Securities, Co., Ltd.
Sep. 2017 President & CEO, Tech & FinStrategy Inc. (to present)
Oct. 2017 Outside Director, Cellspect Co., Ltd. (to present)
Jun. 2018 Outside Director, the Company (to present)
Outside Director, Delta-Fly Pharma, Inc. (to present)
Aug. 2019 Outside Director, Veritas In Silico Inc. (to present)
Aug. 2021 Outside Director, EGAIA Co., Ltd. (to present)
Dec. 2021 Outside Director, RMiC : Regenerative Medicine iPS Gateway Center Co., Ltd. (currently Repli-tech Co., Ltd.) (to present)
Feb. 2022 Director, TransMed, Inc. (to present)

Nobuo HANAI
Outside Director
Date of birth: Apr. 30, 1953

Career
Apr. 1976 Joined Kyowa Hakko Kogyo Co., Ltd.
Feb. 2003 President, BioWa, Inc.
Jun. 2006 Executive Officer, Kyowa Hakko Kogyo Co., Ltd.
Oct. 2008 Operating Director & Head of Development Dept., Kyowa Hakko Kirin Co., Ltd. (currently Kyowa Kirin Co., Ltd.）
Apr. 2009 Managing Executive Officer & Head of Development Dept., Kyowa Kirin Co., Ltd. (Kyowa Kirin)
Jun. 2009 Director & Senior Managing Executive Officer, Kyowa Kirin
Mar. 2010 Director & Executive Operating Officer, Kyowa Kirin
Mar. 2012 Executive Director, President & CEO, Kyowa Kirin
Mar. 2018 Executive Director, Chairman & CEO, Kyowa Kirin
Mar. 2019 Director & Chairman, Kyowa Kirin
May. 2020 Director, Leave a Nest Capital Co., Ltd.
Jun. 2020 Outside Director, Shimadzu Corp. (to present)
Mar. 2021 Outside Director, the Company (to present)
Jun. 2021 Outside Director, Aculys Pharma, Inc.
Oct. 2023 Outside Director, Hepalys Pharma, Inc. (to present)
Dec. 2023 Outside Director, Renalys Pharma, Inc.
Mar. 2024 Outside Director, Noile-Immune Biotech Inc. (to present)
Jun. 2025 Director, Leave a Nest Co.,Ltd. (to present)

Director, Audit & Supervisory Committee Member

Takashi OHNO
Outside Director, Audit & Supervisory Committee Member
Date of birth: Dec. 14, 1969

Career
Mar. 1996 Joined Showa Ota & Co. (currently Ernst & Young ShinNihon LLC)
Oct. 1998 Joined Asahi & Co. (currently KPMG AZSA LLC）
Apr. 2000 Registered as Certified Public Accountant
Apr. 2002 Registered as Certified Public Tax Accountant
Jan. 2006 Joined Ichiyoshi Securities Co., Ltd.
Feb. 2010 Joined CMIC Co., Ltd. (currently CMIC HOLDINGS Co., Ltd.)
Oct. 2016 Representative, Ohno Certified Public Accountant’s Office (to present)
Jun. 2021 Outside Director, Audit & Supervisory Committee Member, the Company (to present)
Jun. 2025 Outside Statutory Auditor, WORKPORT, Inc. (to present)

Takashi MATSUMOTO
Outside Director, Audit & Supervisory Committee Member
Date of birth: Nov. 12, 1962

Career
Apr. 1989 Joined The Nippon Credit Bank, Ltd. (currently Aozora Bank, Ltd.)
Oct. 2001 Head of Investment Group 2, Corporate Investment Department, the Bank
Oct. 2003 Seconded to Aozora Investment Co., Ltd. General Manager of Investment Business Department Ⅰ
May. 2007 General Manager of Business Promotion Department, the Company
Oct. 2007 Managing Director, the Company
Dec. 2009 Joined Innovation Engine Inc. ,Investment Partner (to present)
Jun. 2014 Outside Director , Green Peptide Co., Ltd. (currently BrightPath Bio Co., Ltd.)
Oct. 2016 Outside Director ,ORTHOREBIRTH Co., Ltd.
Dec. 2021 Outside Director ,Veritas In Silico Inc.
Jun. 2026 Outside Director, Audit & Supervisory Committee Member, the Company (to present)

Fusako NISHIGAKI
Outside Director, Audit & Supervisory Committee Member
Date of birth: Sep. 14, 1959

Career
Apr. 1982 Joined Fujisawa Pharmaceutical Co., Ltd. (currently Astellas Pharma Inc.)
Apr. 2005 Research Fellow, Pharmacology Research Labs., Drug Discovery Research, the company
Apr. 2014 Research Fellow, Regenerative Medicine Labs., Drug Discovery Research, the company
Apr. 2014 Vice Chair, Steering Committee of the Forum for Innovation Regenerative Medicine (FIRM)
Apr. 2014 Committee member, Consortium for Human Resource Development in Regenerative Medicine, Ministry of Education, Culture, Sports, Science and Technology
Oct. 2017 Chair, International Affairs Committee, FIRM
Oct. 2019 Manager/Expert, Research Division, HEALIOS K.K.
Jul. 2020 The Evaluation Committee member of " Project for Regenerative Medicine and Cell and Gene Therapies”, Japan Agency for Medical Research and Development (AMED) (to present)
Apr. 2025 Life Science Coordinator, Academic Industry Research Inc. (to present)
May. 2025 Senior Advisor, Medical Grown Co., Ltd. (to present)
Jul. 2025 Advisor, UntroD Capital Japan,Inc. (to present)
Jun. 2026 Outside Director, Audit & Supervisory Committee Member, the Company (to present)

Executive Officer

Hidenori ISHII
Executive Officer, Head of Research Planning and Clinical Development Dept.
Date of birth: Jan. 24, 1964

Career
Apr. 1987 Dainippon Pharmaceutical Co., Ltd. (currently Sumitomo Pharma Co., Ltd.)
Jun. 1992 Kirin Brewery Co., Ltd. (Kirin Brewery) (currently Kyowa Kirin Co., Ltd. (Kyowa Kirin))
Sep. 2006 Manager, General Affairs Department, Pharmaceutical Company, Kirin Brewery
Oct. 2008 Manager, Human Resources Department, Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko Kirin) (currently Kyowa Kirin)
Oct. 2009 Head of Investor Relations Group, Corporate Communications Department, Kyowa Hakko Kirin
Oct. 2015 Senior Manager, External Relations Group, General Affairs Department / Bureau chief, Pharmaceutical Industry Information Research Forum (PI Forum), Kyowa Hakko Kirin
Apr. 2019 Seconded to the Forum for Innovative Regenerative Medicine (FIRM), a general incorporated association, from the same company
Apr. 2024 Senior Manager, Research and Development Division, the Company
Nov. 2024 Head of Research Planning and Clinical Development Department, the Company (to present)
Jun. 2025 Executive Officer, the Company (to present)

Advisors

Fuyuki Ishikawa
Vice President, Kyoto University; Deputy-Director General, Kyoto University Office of Research Acceleration; Program Professor

Career
May. 1982 Passed National Examination for Medical Practitioners
Jun. 1982 Resident, The University of Tokyo Hospital
Jun. 1983 Junior Resident, Jichi Medical University Hospital
Jun. 1984 Hematologist, The Third Dept. of Internal Medicine (Prof. F. Takahisa), The University of Tokyo
Oct. 1984 Research Associate, Carcinogenesis Division, National Cancer Center Research Institute
Apr. 1987 Assistant Professor, The Third Dept. of Internal Medicine, The University of Tokyo Hospital
May. 1990 Ph. D (University of Tokyo)
Oct. 1990 Post Doctoral Fellow, Chemical & Biological Engineering Dept. (Prof. Thomas R. Cech), University of Colorado at Boulder
Oct. 1992 Associate Professor, School of Life Science and Technology, Dept. of Life Science and Technology, Tokyo Institute of Technology
Jan. 1998 Professor, School of Life Science and Technology, Dept. of Life Science and Technology, Tokyo Institute of Technology
Apr. 2002 Professor, Graduate School of Biostudies, Kyoto University
Oct. 2015 The 23rd Member, Secretary of Section II, Science Council of Japan
Oct. 2017 The 24th Member, Chairperson of Section II, Science Council of Japan 2019 President, The 78th Annual Meeting of the Japanese Cancer Association
Oct. 2022 Vice President, Kyoto University; Director, Kyoto University Research Administration Center;　Specially Appointed Professor
Mar. 2023 Emeritus Professor, Graduate School of Biostudies, Kyoto University
Apr. 2024 Vice President, Kyoto University; Director, Kyoto University Research Administration Center;　Program Professor (to present)

Kohei Tsumoto
Professor, School of Engineering, The University of Tokyo
Director, Center for Drug Design Research, National Institutes of Biomedical Innovation, Health and Nutrition

Career
Aug. 1995 Associate Professor, Tohoku University (Bioengineering, School of Engineering)
Aug. 2001 Lecturer, Tohoku University (Bioengineering, School of Engineering)
Oct. 2002 Assistant Professor, Tohoku University (Bioengineering, School of Engineering)
Mar. 2005 Assistant Professor, the University of Tokyo (Medical Genome, Graduate School of Frontier Sciences)
Apr. 2007 Associate Professor, the University of Tokyo (Medical Genome, Graduate School of Frontier Sciences)
May. 2010 Professor, the University of Tokyo (Medical Proteomics Laboratory, The Institute of Medical Science) (to present)
Apr. 2013 Professor, the University of Tokyo (Dept. of Bioengineering, Dept. of Chemistry & Biotechnology, Graduate School of Engineering) (to present)
Apr. 2018 Advisor to President, the University of Tokyo (Administration, Research)
Apr. 2020 Executive Advisor to Director, Graduate School of Engineering (Planning)
Apr. 2021 Executive Advisor to President, the University of Tokyo (University Corporate Relations, Academic Excellence Enhancement) (to present)
Apr. 2023 Deputy Director, Graduate School of Engineering, the University of Tokyo (Education) (to present)

Yuji Kumagai
Emeritus Professor, Kitasato University

Career
Mar. 1989 Doctoral degree, Oita University Graduate School of Medicine
Apr. 1989 Assistant, Clinical Pharmacology, Jichi Medical University
Dec. 1991 Chronobiology, Medical School, University of Minnesota
Jul. 1995 Lecturer, Pharmacology, School of Medicine, Kitasato University
Apr. 2011 Professor, Kitasato Clinical Research Center
Apr. 2013 Director, Kitasato Clinical Research Center
Apr. 2023 Emeritus Professor, Kitasato University
Apr. 2023 Clinical Trial Advisor, Kitasato University Kitasato Institute Hospital